Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Remote Controlled Analgesia on Patient Experience (R-CAPE)

1 de abril de 2020 actualizado por: University Hospital, Montpellier

Effect of Perineural Catheter Analgesia on Patient Experience After Orthopedic Surgery

The main objective of this study is to compare the efficacy of continuous nerve blocks with single injection in terms of perioperative patient satisfaction after scheduled orthopedic ambulatory surgery. Subgroup analyses will be performed, a priori, according to patients Pain Catastrophizing Scale (PCS) and type of surgery.

Secondary objectives comprise the assessment of pain, readmission rates, patient mobilization, quality of sleep and heart rate collected by an activity tracker. Scales about quality of recovery will be performed on day 1, about quality of life on day 45 and presence of neuropathic pain will be screened at 3 months. An economic study will also be conducted, including work resumption at 3 months.

This is a multicentric prospective study. Three hundred patients will be randomized in two parallel groups: continuous nerve blocks delivered thru remote-controlled electronic pump versus single local anesthetics injection.

The primary endpoint is the EVAN-G patient satisfaction scale, scored at day 2. Secondary endpoints will include assessment of pain, opiates consumption, sensitivity and motricity scores, rate of catheter falls at home, hospital readmission, patient mobilization, sleep and heart rate as assessed by an activity tracker, PCS before the surgery and Quality of Recovery (QoR-40) scale at day 1, Short-Form 36 (SF36) at day 45 and Neuropathic Pain assessment (DN4) at day 90.

Descripción general del estudio

Estado

Terminado

Condiciones

Descripción detallada

Acute postoperative pain is poorly treated. More than three-quarters of patients complain of pain, from moderate to extreme, after surgery. In orthopedic surgery, continuous nerve blocks analgesia has proved effective among in-hospital patients but single injection strategy is easier to implement in the growing outpatient setting.

The main objective of this study is to compare the efficacy of continuous nerve blocks with single injection in terms of perioperative patient satisfaction after scheduled orthopedic ambulatory surgery. Subgroup analyses will be performed, a priori, according to patients Pain Catastrophizing Scale (PCS) and type of surgery.

Secondary objectives comprise the assessment of pain, readmission rates, patient mobilization, quality of sleep and heart rate collected by an activity tracker. Scales about quality of recovery will be performed on day 1, about quality of life on day 45 and presence of neuropathic pain will be screened at 3 months. An economic study will also be conducted, including work resumption at 3 months.

The inclusion criteria are adults undergoing outpatient scheduled orthopedic surgery under general anesthesia with regional analgesia.

Non-inclusion criteria are patients over 80 years, documented cognitive impairment, inability to complete a self-administered questionnaire, presenting American Society of Anesthesiology (ASA) physical status 3 unsteady or 4, or spontaneously requiring analgesic perineural catheter or a single injection of local anesthetics.

This is a multicentric prospective study. Three hundred patients will be randomized in two parallel groups: continuous nerve blocks delivered thru remote-controlled electronic pump versus single local anesthetics injection.

The primary endpoint is the EVAN-G patient satisfaction scale, scored at day 2. Secondary endpoints will include assessment of pain, opiates consumption, sensitivity and motricity scores, rate of catheter falls at home, hospital readmission, patient mobilization, sleep and heart rate as assessed by an activity tracker, PCS before the surgery and Quality of Recovery (QoR-40) scale at day 1, Short-Form 36 (SF36) at day 45 and Neuropathic Pain assessment (DN4) at day 90.

Tipo de estudio

Intervencionista

Inscripción (Actual)

300

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Montpellier, Francia, 34295
        • Department of Anesthesiology and critical care, Lapeyronie University Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 80 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Male or female subject aged 18 or more, up to 80 years;
  • Undergoing potentially painful scheduled orthopedic surgery under general anesthesia.
  • Eligible to outpatient care;
  • Respecting the ambivalence clause defined below:

    1. no cons-indication to analgesic perineural catheter;
    2. not known allergy to local anesthetics;
    3. likely to be a candidate for continuous nerve block analgesia;
  • Ability to complete a self-reported questionnaire;
  • Have given written informed consent

Exclusion Criteria:

  • Age less than 18 or more than 80 years;
  • Pregnant or nursing women ;
  • Not being affiliated to the social security scheme;
  • Known allergy to local anesthetics of the amide type;
  • Regulatory constraints in the outpatient management of perineural catheters not respected:

    1. Inability of daily nursing care;
    2. No presence of a responsible adult at home the night of the intervention;
  • Scheduled hospital stay;
  • ASA physical status score (American Society of Anesthesiologists) above 3 or 3 unsteady;
  • Spontaneous request for continuous nerve block or single injection;
  • Topic unable to fulfill only a self-administered questionnaire (inability to read French, severe cognitive impairment);
  • Subject with cognitive impairment already documented (Alzheimer, dementia, neurological sequelae);
  • Topic treated with antipsychotics (neuroleptics or lithium);
  • Subject has a documented chronic pain syndrome;
  • Active consumer of narcotic topic;
  • Topic have not signed informed consent.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Electronic pump
Continuous nerve blocks Remote-controlled perineural local anesthetics delivery
Remote-controlled perineural local anesthetics delivery
Sin intervención: single injection

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Patient experience and satisfaction scale (EVAN-G)
Periodo de tiempo: Second day after surgery
Description: Patient experience and satisfaction scale
Second day after surgery

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Patient quality of recovery (QoR)
Periodo de tiempo: First day after surgery
Description: Patient quality of recovery
First day after surgery

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Silla de estudio: Xavier CAPDEVILA, M.D., Ph.D., University Hospital, Montpellier

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

7 de junio de 2016

Finalización primaria (Actual)

21 de octubre de 2019

Finalización del estudio (Actual)

2 de diciembre de 2019

Fechas de registro del estudio

Enviado por primera vez

22 de marzo de 2016

Primero enviado que cumplió con los criterios de control de calidad

25 de marzo de 2016

Publicado por primera vez (Estimar)

28 de marzo de 2016

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

3 de abril de 2020

Última actualización enviada que cumplió con los criterios de control de calidad

1 de abril de 2020

Última verificación

1 de marzo de 2016

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir